As artificial intelligence becomes increasingly embedded in formulation science and early clinical planning, the industry faces a dual challenge: accelerating timelines while safeguarding scientific rigor, patient safety, and regulatory trust. In thi... Read more
Under the leadership of Joel Latham, Incannex Healthcare is advancing a differentiated pipeline of cannabinoid- and psychedelic-based therapeutics targeting significant unmet needs in sleep disorders, inflammatory disease, and anxiety... Read more
As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperative. From decarbonizing complex global supply chains to embedding environmental governance into... Read more
As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations (CDMOs) and their clients determines the program efficiency, outcome quality, and supply reliab... Read more
Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be accretive to Agilent’s top-line gro... Read more
Cure Rare Disease (CRD), a non-profit biotechnology organization, announced a landmark partnership with the LGMD2L Foundation. This collaboration is backed by a generous commitment of $7.65 million from the LGMD2L Foundation to develop a nove... Read more
BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation industries, announced that CordenPharma Colorado, a leading peptide drug substance Contract Development and Manufacturing Organizat... Read more
-Forma Life Sciences, Inc. announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product m... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
